Education
About Us
Working with TipRanks
Follow Us
Amgen (HK:4332)
:4332
Total Valuation
Amgen has a market cap or net worth of $1.34T. The enterprise value is HK$198.09B.
Market Cap$1.34T
Enterprise ValueHK$198.09B
Share Statistics
Amgen has 538,480,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding538,480,650
Owned by Insiders0.19%
Owned by Institutions3.52%
Financial Efficiency
Amgen’s return on equity (ROE) is 0.70 and return on invested capital (ROIC) is 8.90%.
Return on Equity (ROE)0.70
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)8.90%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee1.19M
Profits Per Employee146.07K
Employee Count28,000
Asset Turnover0.36
Inventory Turnover1.84
Valuation Ratios
The current PE Ratio of Amgen is <0.1. Amgen’s PEG ratio is -0.88.
PE Ratio<0.1
PS Ratio4.22
PB Ratio23.99
Price to Fair Value23.99
Price to FCF13.57
Price to Operating Cash Flow13.11
PEG Ratio-0.88
Income Statement
In the last 12 months, Amgen had revenue of 33.42B and earned 4.09B in profits. Earnings per share was 7.56.
Revenue33.42B
Gross Profit20.57B
Operating Income7.26B
Pretax Income4.61B
Net Income4.09B
EBITDA13.36B
Earnings Per Share (EPS)7.56
Cash Flow
In the last 12 months, operating cash flow was 13.13B and capital expenditures -1.59B, giving a free cash flow of 11.54B billion.
Operating Cash Flow13.13B
Free Cash Flow11.54B
Free Cash Flow per Share21.43
Dividends & Yields
Amgen pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.07
52-Week Price Change-99.99%
50-Day Moving Average1.73K
200-Day Moving Average1.73K
Relative Strength Index (RSI)0.02
Average Volume (3m)0.00
Important Dates
Amgen upcoming earnings date is Feb 3, 2026, After Close (Confirmed).
Last Earnings DateNov 4, 2025
Next Earnings DateFeb 3, 2026
Ex-Dividend Date―
Financial Position
Amgen as a current ratio of 1.26, with Debt / Equity ratio of 567.49%
Current Ratio1.26
Quick Ratio0.95
Debt to Market Cap0.43
Net Debt to EBITDA3.66
Interest Coverage Ratio2.30
Taxes
In the past 12 months, Amgen has paid 519.00M in taxes.
Income Tax519.00M
Effective Tax Rate0.11
Enterprise Valuation
Amgen EV to EBITDA ratio is 14.22, with an EV/FCF ratio of 18.27.
EV to Sales5.68
EV to EBITDA14.22
EV to Free Cash Flow18.27
EV to Operating Cash Flow16.53
Balance Sheet
Amgen has $9.45B in cash and marketable securities with $54.59B in debt, giving a net cash position of -$45.14B billion.
Cash & Marketable Securities$9.45B
Total Debt$54.59B
Net Cash-$45.14B
Net Cash Per Share-$83.83
Tangible Book Value Per Share-$74.79
Margins
Gross margin is 66.15%, with operating margin of 21.71%, and net profit margin of 12.24%.
Gross Margin66.15%
Operating Margin21.71%
Pretax Margin13.79%
Net Profit Margin12.24%
EBITDA Margin39.96%
EBIT Margin23.23%
Analyst Forecast
The average price target for Amgen is $2,503.63, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2,503.63
Price Target Upside1390807.42% Upside
Analyst ConsensusModerate Buy
Analyst Count18
Revenue Growth Forecast―
EPS Growth Forecast―